InfuSystem Inc. (INFU)
AMEX: INFU
· Real-Time Price · USD
9.49
0.17 (1.82%)
At close: Aug 14, 2025, 3:59 PM
9.58
0.95%
After-hours: Aug 14, 2025, 05:50 PM EDT
InfuSystem Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 |
|---|---|---|
| Device Solutions Revenue | 61.74M | 55.83M |
| Device Solutions Revenue Growth | +10.59% | n/a |
| Patient Services Revenue | 80.38M | 76.54M |
| Patient Services Revenue Growth | +5.01% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 16.34M | 18.55M | 15.35M | 15.53M | 14.57M | 17.07M | 13.26M | 14.47M | 15.01M | 15.29M | 14.52M | 14.66M | 14.02M | 15.13M | 12.54M | 14.47M | 13.3M | 12.73M | 12.64M | 10.78M | 10.16M | 11.27M | 10.56M | 9.5M | 9.26M | 9.64M | 8.58M | 8.48M | 8.59M | 8.3M | 9.09M | 7.82M | 8.72M | 9.35M | 8.33M | 7.76M | 8.72M | 9.48M | 8.47M | 8.34M | 8.68M | 8.71M |
| Selling, General, and Administrative Revenue Growth | -11.88% | +20.82% | -1.16% | +6.63% | -14.67% | +28.72% | -8.35% | -3.62% | -1.77% | +5.30% | -1.00% | +4.55% | -7.34% | +20.72% | -13.38% | +8.85% | +4.45% | +0.68% | +17.26% | +6.14% | -9.86% | +6.72% | +11.18% | +2.56% | -3.89% | +12.29% | +1.16% | -1.27% | +3.54% | -8.66% | +16.13% | -10.29% | -6.75% | +12.27% | +7.37% | -11.00% | -8.10% | +11.96% | +1.60% | -3.95% | -0.36% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue | 2.7M | 2.98M | 2.14M | 2.75M | 3.04M | 3.38M | 3.72M | 2.73M | 2.98M | 3.22M | 2.96M | 2.89M | 3.08M | 3.32M | 2.81M | 2.91M | 2.68M | 2.38M | 2.4M | 2.2M | 2.45M | 2.62M | 2.45M | 2.4M | 2.48M | 2.6M | 2.16M | 2.32M | 2.33M | 2.3M | 2.34M | 2.26M | 2.29M | 2.89M | 2.03M | 2.49M | 2.32M | 2.81M | 2.35M | 2.65M | 2.69M | 2.74M |
| Sales and Marketing Revenue Growth | -9.41% | +39.55% | -22.36% | -9.43% | -9.89% | -9.17% | +36.25% | -8.61% | -7.41% | +8.81% | +2.38% | -6.13% | -7.11% | +17.99% | -3.27% | +8.51% | +12.79% | -0.92% | +9.20% | -10.33% | -6.46% | +6.77% | +2.08% | -2.99% | -4.84% | +20.63% | -7.15% | -0.13% | +1.09% | -1.50% | +3.27% | -1.44% | -20.48% | +42.31% | -18.55% | +7.14% | -17.44% | +20.04% | -11.68% | -1.19% | -1.83% | n/a |